Cubist Systematic Strategies’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.2M | Buy |
+817,748
| New | +$15.3M | 0.07% | 376 |
|
|
2024
Q4 | – | Sell |
-34,066
| Closed | -$634K | – | 3499 |
|
|
2024
Q3 | $634K | Buy |
+34,066
| New | +$574K | ﹤0.01% | 2097 |
|
|
2024
Q1 | – | Sell |
-60,131
| Closed | -$858K | – | 4208 |
|
|
2023
Q4 | $858K | Buy |
+60,131
| New | +$854K | 0.01% | 2165 |
|
|
2023
Q2 | – | Sell |
-148,497
| Closed | -$1.71M | – | 4209 |
|
|
2023
Q1 | $1.71M | Buy |
148,497
+148,460
| +401,243% | +$1.84M | 0.01% | 1782 |
|
|
2022
Q4 | $460 | Sell |
37
-11,498
| -100% | -$147K | ﹤0.01% | 4167 |
|
|
2022
Q3 | $151K | Buy |
11,535
+9,144
| +382% | +$135K | ﹤0.01% | 3881 |
|
|
2022
Q2 | $33K | Sell |
2,391
-241,382
| -99% | -$3.23M | ﹤0.01% | 4162 |
|
|
2022
Q1 | $3.63M | Sell |
243,773
-200,328
| -45% | -$2.74M | 0.03% | 985 |
|
|
2021
Q4 | $6.01M | Buy |
444,101
+334,496
| +305% | +$4.73M | 0.06% | 524 |
|
|
2021
Q3 | $1.61M | Sell |
109,605
-131,313
| -55% | -$2.22M | 0.02% | 1181 |
|
|
2021
Q2 | $4.38M | Buy |
240,918
+112,497
| +88% | +$2M | 0.05% | 618 |
|
|
2021
Q1 | $2.23M | Buy |
128,421
+64,781
| +102% | +$1.14M | 0.03% | 954 |
|
|
2020
Q4 | $1.1M | Buy |
63,640
+29,204
| +85% | +$466K | 0.02% | 1321 |
|
|
2020
Q3 | $475K | Buy |
34,436
+20,364
| +145% | +$299K | 0.01% | 1785 |
|
|
2020
Q2 | $203K | Sell |
14,072
-102,460
| -88% | -$1.35M | ﹤0.01% | 2024 |
|
|
2020
Q1 | $1.27M | Sell |
116,532
-221,291
| -66% | -$4.08M | 0.03% | 685 |
|
|
2019
Q4 | $7.21M | Buy |
337,823
+296,218
| +712% | +$6.63M | 0.13% | 176 |
|
|
2019
Q3 | $955K | Buy |
41,605
+5,603
| +16% | +$120K | 0.02% | 991 |
|
|
2019
Q2 | $709K | Buy |
36,002
+8,479
| +31% | +$165K | 0.01% | 1245 |
|
|
2019
Q1 | $536K | Sell |
27,523
-6,761
| -20% | -$128K | 0.02% | 1148 |
|
|
2018
Q4 | $565K | Buy |
+34,284
| New | +$690K | 0.03% | 892 |
|
|
2018
Q3 | – | Sell |
-26,837
| Closed | -$583K | – | 2057 |
|
|
2018
Q2 | $583K | Sell |
26,837
-53,446
| -67% | -$1.04M | 0.03% | 719 |
|
|
2018
Q1 | $1.42M | Buy |
80,283
+37,547
| +88% | +$662K | 0.08% | 316 |
|
|
2017
Q4 | $802K | Sell |
42,736
-42,667
| -50% | -$849K | 0.04% | 606 |
|
|
2017
Q3 | $1.87M | Buy |
85,403
+84,353
| +8,034% | +$1.91M | 0.1% | 193 |
|
|
2017
Q2 | $25K | Buy |
+1,050
| New | +$26.7K | ﹤0.01% | 1596 |
|
|
2016
Q3 | – | Sell |
-23,886
| Closed | -$493K | – | 1848 |
|
|
2016
Q2 | $493K | Buy |
23,886
+11,786
| +97% | +$246K | 0.03% | 776 |
|
|
2016
Q1 | $243K | Buy |
+12,100
| New | +$232K | 0.01% | 1101 |
|
|
2015
Q4 | – | Sell |
-15,748
| Closed | -$365K | – | 1918 |
|
|
2015
Q3 | $365K | Buy |
+15,748
| New | +$402K | 0.02% | 1132 |
|
|
2015
Q2 | – | Sell |
-9,779
| Closed | -$324K | – | 2018 |
|
|
2015
Q1 | $324K | Buy |
+9,779
| New | +$317K | 0.02% | 1207 |
|
Other funds holding SBRA
EGM
N
Cubist Systematic Strategies's SBRA Position: Q3 2025 in Review
Cubist Systematic Strategies opened a new position in Sabra Healthcare REIT (SBRA) in Q3 2025: 817,748 shares worth $15.2M. The stake represents 0.07% of the portfolio and ranks #376 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in SBRA as recently as Q3 2024.
Cubist Systematic Strategies first reported a position in SBRA in Q1 2015 and has held it in 30 quarters since. 424 funds tracked by Wall St. Rank hold SBRA as of Q3 2025.
- Cubist Systematic Strategies held 817,748 shares of Sabra Healthcare REIT worth $15.2M as of Q3 2025.
- Sabra Healthcare REIT was a new Cubist Systematic Strategies position in Q3 2025.
- Sabra Healthcare REIT made up 0.07% of Cubist Systematic Strategies's portfolio in Q3 2025, its #376 holding.
- Cubist Systematic Strategies first reported a position in Sabra Healthcare REIT in Q1 2015 and has held it in 30 quarters since.
- 424 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.